In 1972 Wilson Greatbatch introduced lithium‑iodide batteries for implantable pacemakers, extending device life from one‑to‑two years to over a decade. This chemistry replaced unreliable mercury‑zinc cells, enabling consistent voltage output and dramatically reducing replacement surgeries. The longer power window enabled smaller enclosures, expanding implants to pediatric and elderly patients. The breakthrough set a new reliability benchmark that still underpins modern cardiac rhythm management devices.
Quantum Surgical has acquired NeuWave Medical, creating the Precision IO Group as a new parent company. The deal combines Quantum’s Epione robotic platform with NeuWave’s microwave ablation technology, already used in over 70 percent of top U.S. cancer centers. The integration aims to...
Quantum Surgical announced the acquisition of NeuWave Medical, Inc., a leading microwave ablation device maker used in over 70% of top U.S. cancer centers. The deal creates Precision IO Group Inc., a new parent company that will house both businesses, aiming to democratize...
Robotic platforms once confined to operating rooms are now entering rehabilitation, driven by sensor integration and real‑time data processing. Analysts project the global medical robotics market to exceed $30 billion by 2030, with assistive devices gaining a larger share. ATDev’s founders...